NCT01674556View on ClinicalTrials.gov

Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Pancreatic Adenocarcinoma
Interventions
DRUG

Gemzar

Gemcitabine in combination with ultrasound (US) contrast agent under sonication

Trial Locations (1)

Unknown

Haukeland University Hospital, Bergen

All Listed Sponsors
lead

Haukeland University Hospital

OTHER

NCT01674556 - Ultrasound-assisted Treatment of Inoperable Pancreatic Cancer | Biotech Hunter | Biotech Hunter